HTCR HTCR
Company Profile ↓Company Overview
HTCR (HTCR) is a publicly traded company listed on with a market capitalization of $3.34M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Generates a return on equity of 66.0%, reflecting efficient use of shareholder capital.
Net profit has compounded at 107.4% per year over the last five years.
Trades at an undemanding P/E of 11.9.
Maintains a net profit margin of 64.6%.
Carries low leverage with a debt-to-equity ratio of 0.09.
Recent Developments
- Dec 2025 Revenue of $8.97M (-60.5% YoY); net profit $5.79M.
- Trailing 12 Months Year-on-year growth — revenue -60.5%.
- 5-Year Trend Long-term compounding — revenue CAGR -0.1%, profit CAGR 107.4%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | -0.13% |
| 1 Year: | -60.46% |
Compounded Profit Growth
| 5 Years: | 107.41% |
| 1 Year: | - |
Stock Price Performance
| 1 Year: | -67.68% |
| 6 Months: | -49.42% |
| 3 Months: | -18.58% |
| 1 Month: | -14.61% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)49.91 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Strong return on equity of 66.0%.
- Excellent profit margin of 64.6%.
- Profit CAGR of 107.4% over 5 years.
CONS
- Revenue declined at -0.1% CAGR over 5 years.
- Trading 88.0% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Mar 2021 | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.11M | 2.87M | 3.47M | 2.28M | 2.67M | 1.87M | 8.73M | 5.10M | 4.69M | 5.05M | 4.07M | 16.24M | 2.09M | - | 2.99M | 1.25M |
| Gross Profit | 702.68K | 1.69M | 1.68M | 1.22M | 1.33M | 329.22K | 5.63M | 1.51M | 828.67K | 2.03M | 805.88K | 14.01M | 543.77K | 2.22M | 1.47M | 74.05K |
| Operating Income | -158.56K | 487.81K | 212.56K | -1.56M | -1.66M | -2.01M | 2.30M | -1.47M | -1.79M | -682.96K | -1.51M | 12.34M | -1.19M | 107.47K | -11.15K | -1.54M |
| Net Income | -183.25K | 400.79K | 186.17K | -1.58M | -1.70M | -1.97M | 1.88M | -911.80K | -2.31M | -1.33M | -1.95M | 11.06M | -3.09M | 1.10M | 434.07K | -1.87M |
| Diluted EPS | -0.01 | 0.03 | 0.01 | -0.09 | -0.09 | -0.11 | 0.10 | -0.04 | -0.11 | -0.06 | -0.09 | 0.53 | -2.80 | 0.04 | 0.02 | -1.49 |
| R&D Expense | 52.15K | 80.03K | 189.69K | 108.26K | 417.23K | 58.27K | 79.62K | 39.61K | 170.07K | 89.13K | 111.27K | 63.71K | 123.89K | 161.48K | - | - |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|
| Revenue | 9.03M | 10.82M | 8.82M | 21.85M | 22.69M | 8.97M |
| Gross Profit | 4.02M | 5.19M | 3.35M | 8.07M | 14.72M | 3.15M |
| Operating Income | 258.70K | 59.02K | -6.70M | -4.12M | -161.71K | -3.12M |
| Net Income | 150.96K | -338.16K | -6.68M | -4.19M | -1.48M | 5.79M |
| Diluted EPS | 0.01 | -0.02 | -0.37 | -0.21 | -0.07 | 0.22 |
| R&D Expense | 311.05K | 510.74K | 641.02K | 1.02M | 179.76K | - |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|
| Total Assets | - | 10.36M | - | 12.14M | 19.62M | 13.97M | 13.06M |
| Current Assets | - | - | - | 8.54M | 5.49M | 9.42M | 8.42M |
| Cash & Equivalents | - | 3.06M | - | 7.18M | 1.01M | 1.97M | 1.99M |
| Inventory | - | - | - | - | - | - | - |
| Receivables | - | - | - | 551.06K | 2.62M | 1.03M | 707.87K |
| Total Liabilities | - | 10.96M | - | 7.33M | 11.96M | 10.50M | 5.78M |
| Current Liabilities | - | 3.67M | - | 3.65M | 6.51M | 7.42M | 5.33M |
| Long Term Debt | - | 3.02M | - | 1.12M | 1.77M | 498.71K | 448.38K |
| Total Debt | - | - | - | 4.55M | 4.89M | 1.05M | 756.18K |
| Total Equity | -1.63M | -958.01K | - | 4.81M | 5.17M | 4.65M | 8.78M |
| Shares Outstanding | - | - | - | 882.49K | 1.04M | 1.10M | 1.27M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 745.75K | 766.30K | -4.81M | -4.33M | -4.77M | - |
| Investing Cash Flow | -401.15K | -179.03K | -12.20K | -1.78M | 6.35M | - |
| Financing Cash Flow | 2.06M | -257.35K | 8.92M | 136.19K | -318.65K | - |
| Capital Expenditure | -27.17K | -36.15K | -57.07K | -526.26K | -7.45K | - |
| Free Cash Flow | 718.58K | 730.15K | -4.87M | -4.86M | -4.78M | - |
| Share Buybacks | - | - | 3.50M | - | - | - |
| Dividends Paid | - | - | - | - | 834.57K | 3.30M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|
| Gross Margin % | 44.5% | 47.9% | 38.0% | 36.9% | 64.9% | 35.1% |
| Operating Margin % | 2.9% | 0.5% | -75.9% | -18.9% | -0.7% | -34.8% |
| Net Margin % | 1.7% | -3.1% | -75.7% | -19.2% | -6.5% | 64.6% |
| ROE % | -15.8% | - | -138.9% | -81.1% | -31.8% | 66.0% |
| ROCE % | 3.9% | - | -78.9% | -31.4% | -2.5% | -40.4% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for HTCR
HeartCore Completes Strategic Divestiture of Sigmaways
Transaction advances portfolio optimization strategy, reduces exposure to non-core loss-making operations, and supports focus on cornerstone capital markets and financial services initiativesNEW YORK and TOKYO, June 25, 2026 (GLOBE NEWSWIRE…
HeartCore Reports First Quarter 2026 Financial Results
NEW YORK and TOKYO, May 15, 2026 (GLOBE NEWSWIRE) -- HeartCore Enterprises, Inc. (Nasdaq: HTCR) (“HeartCore” or the “Company”), an IPO consulting services company based in Tokyo, reported financial results for the first quarter ended March …
HeartCore Regains Compliance with Nasdaq Minimum Bid Price Requirement
NEW YORK and TOKYO, April 22, 2026 (GLOBE NEWSWIRE) -- HeartCore Enterprises, Inc. (Nasdaq: HTCR) (“HeartCore” or the “Company”), an IPO consulting services company based in Tokyo, today announced that on April 20, 2026, it received written…
HeartCore Announces 1-for-20 Reverse Stock Split
NEW YORK and TOKYO, April 01, 2026 (GLOBE NEWSWIRE) -- HeartCore Enterprises, Inc. (NASDAQ: HTCR) (“HeartCore” or the “Company”), an IPO consulting services company based in Tokyo, today announced that its Board of Directors approved a 1-fo…
HeartCore Reports Full Year 2025 Results
NEW YORK and TOKYO, March 31, 2026 (GLOBE NEWSWIRE) -- HeartCore Enterprises, Inc. (Nasdaq: HTCR) (“HeartCore” or the “Company”), an IPO consulting services company based in Tokyo, reported financial results for the full year ended December…
HeartCore Authorizes $2.0 Million Share Repurchase Program as Part of Disciplined Capital Allocation Strategy
NEW YORK and TOKYO, Feb. 24, 2026 (GLOBE NEWSWIRE) -- HeartCore Enterprises, Inc. (NASDAQ: HTCR) (“HeartCore” or the “Company”), an IPO consulting services company based in Tokyo, today announced that its Board of Directors has authorized a…
HTCR — Frequently Asked Questions
What is the current share price of HTCR?
As of 2026-08-05 17:25 PDT, HTCR trades at $2.63 on NASDAQ/NYSE. Its 52-week range is $2.10 to $21.96.
What is the market capitalisation of HTCR?
HTCR has a market capitalisation of $3.34M on NASDAQ/NYSE.
What is the P/E ratio of HTCR?
HTCR trades at a trailing price-to-earnings (P/E) ratio of 11.95. Its price-to-book (P/B) ratio is 0.38.
What is the return on equity (ROE) of HTCR?
HTCR has a return on equity (ROE) of 65.99%. Its return on capital employed (ROCE) is -40.37%.
Is HTCR a good stock to buy?
This page provides a data-driven analysis of HTCR, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.